USFDA concludes inspection at Zydus Lifesciences’ formulation manufacturing plant at Baddi

14 Aug 2025 Evaluate

US Food and Drug Administration (USFDA) has conducted a surveillance inspection at Zydus Lifesciences’ formulation manufacturing plant located at Baddi in Himachal Pradesh. The inspection was conducted from August 4, 2025 to August 13, 2025.

The inspection concluded with 4 observations. There were no data integrity related observations. The company will closely work with the USFDA to address the observations expeditiously. 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.


Zydus Lifesciences Share Price

933.10 -2.10 (-0.22%)
05-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×